Literature DB >> 26318860

Double-negative feedback loop between long non-coding RNA TUG1 and miR-145 promotes epithelial to mesenchymal transition and radioresistance in human bladder cancer cells.

Jiemei Tan1, Kaifeng Qiu2, Mingyi Li2, Ying Liang3.   

Abstract

LncRNAs have a critical role in the regulation of cellular processes such as cancer progression and metastasis. In the present study, we confirmed that TUG1 was overexpressed in bladder cancer tissues and established cell lines. Knockdown of TUG1 inhibited bladder cancer cell metastasis both in vitro and in vivo. Furthermore, we found that TUG1 promoted cancer cell invasion and radioresistance through inducing epithelial-to-mesenchymal transition (EMT). Interestingly, TUG1 decreased the expression of miR-145 and there was a reciprocal repression between TUG1 and miR-145 in an Argonaute2-dependent manner. ZEB2 was identified as a down-stream target of miR-145 and TUG1 exerted its function through the miR-145/ZEB2 axis. In summary, our data indicated that blocking TUG1 function may be an effective anti-cancer therapy.
Copyright © 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bladder cancer; Epithelial-to-mesenchymal transition; Radioresistance; TUG1; ZEB2; miR-145

Mesh:

Substances:

Year:  2015        PMID: 26318860     DOI: 10.1016/j.febslet.2015.08.020

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  78 in total

1.  Urinary expression of long non-coding RNA TUG1 in non-diabetic patients with glomerulonephritides.

Authors:  Fernando Javier Salazar-Torres; Miguel Medina-Perez; Zesergio Melo; Claudia Mendoza-Cerpa; Raquel Echavarria
Journal:  Biomed Rep       Date:  2020-11-20

2.  Long non-coding RNA TUG1 promotes the proliferation of colorectal cancer cells through regulating Wnt/β-catenin pathway.

Authors:  Chun Hong Xiao; Hai Zhong Yu; Chun Yan Guo; Zhi Mei Wu; Hong Yan Cao; Wei Bing Li; Jian Fen Yuan
Journal:  Oncol Lett       Date:  2018-08-03       Impact factor: 2.967

Review 3.  Epigenetic impacts of endocrine disruptors in the brain.

Authors:  Deena M Walker; Andrea C Gore
Journal:  Front Neuroendocrinol       Date:  2016-09-20       Impact factor: 8.606

Review 4.  Role of taurine, its haloamines and its lncRNA TUG1 in both inflammation and cancer progression. On the road to therapeutics? (Review).

Authors:  Stella Baliou; Anthony M Kyriakopoulos; Demetrios A Spandidos; Vassilios Zoumpourlis
Journal:  Int J Oncol       Date:  2020-07-14       Impact factor: 5.650

5.  Knockdown of LncRNA ANRIL suppresses cell proliferation, metastasis, and invasion via regulating miR-122-5p expression in hepatocellular carcinoma.

Authors:  Ji Ma; Tengfei Li; Xinwei Han; Huifeng Yuan
Journal:  J Cancer Res Clin Oncol       Date:  2017-11-10       Impact factor: 4.553

6.  Radiation-Induced Long Noncoding RNAs in a Mouse Model after Whole-Body Irradiation.

Authors:  Molykutty J Aryankalayil; Sunita Chopra; Joel Levin; Iris Eke; Adeola Makinde; Shaoli Das; Uma Shankavaram; Claire Vanpouille-Box; Sandra Demaria; C Norman Coleman
Journal:  Radiat Res       Date:  2018-01-08       Impact factor: 2.841

Review 7.  Long non-coding RNA expression in bladder cancer.

Authors:  Mohammad Taheri; Mir Davood Omrani; Soudeh Ghafouri-Fard
Journal:  Biophys Rev       Date:  2017-12-08

8.  Inhibiting malignant phenotypes of the bladder cancer cells by silencing long noncoding RNA SChLAP1.

Authors:  Jianjun Zhang; Zhenfeng Shi; Yukui Nan; Ming Li
Journal:  Int Urol Nephrol       Date:  2016-02-09       Impact factor: 2.370

Review 9.  Epigenetic Alterations in Bladder Cancer.

Authors:  Sima P Porten
Journal:  Curr Urol Rep       Date:  2018-10-24       Impact factor: 3.092

10.  Overexpression of long non-coding RNA TUG1 predicts poor prognosis and promotes cancer cell proliferation and migration in high-grade muscle-invasive bladder cancer.

Authors:  Robert Iliev; Renata Kleinova; Jaroslav Juracek; Jan Dolezel; Zuzana Ozanova; Michal Fedorko; Dalibor Pacik; Marek Svoboda; Michal Stanik; Ondrej Slaby
Journal:  Tumour Biol       Date:  2016-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.